Cheapest Semaglutide Providers in 2026 — Ranked & Reviewed

Looking for the cheapest semaglutide in 2026? We ranked every legitimate telehealth provider in our database by their lowest published monthly price for semaglutide. No bait-and-switch teaser pricing — only providers that publish real, transparent costs. Compare and pick the lowest legit option below.

Lowest verified price: $49/mo491 providers compared

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

491 cheapest semaglutide providers compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1CollectiveVisit
2SnagRxVisit
3Ivim HealthVisit
4EmbodyVisit
5GobyMedsVisit

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick
    Collective

    the lowest flat medication price if you can absorb an annual membership fee

    From /mo
    $59
    Flat at every dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
    Visit →
  • Best Budget
    SnagRx

    compounded semaglutide and tirzepatide at a flat lifetime price

    From /mo
    $69
    Flat at every dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
    Visit →
  • Ivim Health

    budget-conscious shoppers

    From /mo
    $75
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
    Visit →
  • Nationwide Coverage
    Embody

    low flat-rate compounded GLP-1 pricing at every dose

    From /mo
    $79
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • GobyMeds

    budget-conscious shoppers

    From /mo
    $93
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
    Visit →
  • bmiMD

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • CoreAge Rx

    best overall value

    From /mo
    $99
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
  • Found

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
    Visit →
6scored dimensions
491cheapest semaglutide providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

Collective

Verified partner

Best for: the lowest flat medication price if you can absorb an annual membership fee

8.3

Collective (collective.org) is a membership-based telehealth platform from the founder of Thrive Market, selling compounded semaglutide and tirzepatide at a flat price on every dose. Medication is billed separately from a required annual membership, and the program bundles unlimited clinician messaging, dietitian access and express cold shipping.

Score Breakdown

Value25%
9.4
Effectiveness25%
8.2
User Experience15%
8
Trust & Safety15%
7.2
Accessibility10%
7.4
Support10%
8.4

Pros

  • ✓The lowest published compounded GLP-1 medication prices we track — $59/month semaglutide and $69/month tirzepatide
  • ✓Flat pricing at every dose, so titrating up does not raise the bill
  • ✓Unlimited clinician messaging and registered-dietitian access are included rather than upsold
  • ✓21-day free trial on the membership before the annual fee is charged

Cons

  • ✗The advertised $59 and $69 exclude a mandatory $199 annual membership — the real first-year cost is $907 and $1,027
  • ✗Membership fees are non-refundable and no partial-period refunds are given
  • ✗Compounding pharmacies are described only as 'independent, third-party licensed pharmacies' and are never named
  • ✗State availability is not published on the marketing site
Starting from $59/moRead full review →
Visit Collective →
2

SnagRx

Verified partner

Best for: compounded semaglutide and tirzepatide at a flat lifetime price

7.8

SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc. offering compounded semaglutide and compounded tirzepatide shipped to your door in 1-2 days. Pricing is flat for life at the same price every dose: $99/mo for semaglutide and $149/mo for tirzepatide on the one-month billing cycle, falling only if you prepay a longer cycle. No insurance, no membership; telehealth visit and shipping included.

Score Breakdown

Value25%
8.5
Effectiveness25%
7.5
User Experience15%
7.5
Trust & Safety15%
7.8
Accessibility10%
7.5
Support10%
7.4

Pros

  • ✓Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) month-to-month, flat-priced at every dose; longer commitments cut it to $69/$119
  • ✓Names four partner pharmacies (Red Rock, Health Warehouse, Precision Medicine, Triad Rx)
  • ✓Serves every US state except Louisiana according to the site FAQ, with Nebraska limited to patients 19 and older
  • ✓Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
  • ✓Cancel anytime, and the dose ladder is published in the homepage FAQ rather than held back until intake

Cons

  • ✗The struck-through anchors ($299 semaglutide, $349 tirzepatide) sit beside a countdown that restarts rather than a real deadline
  • ✗No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
  • ✗All payments are final at purchase; a medical disqualification refunds the unused portion minus any care already delivered
  • ✗The Terms claim all 50 states plus D.C. while the FAQ excludes Louisiana, and the intake dropdown still lists it
  • ✗Binding JAMS arbitration under Delaware law; class-action waiver
Starting from $69/moRead full review →
Visit SnagRx →
3

Ivim Health

Verified partner

Best for: budget-conscious shoppers

7.7

Telehealth weight loss program with low entry-tier semaglutide pricing and a separate program fee for tirzepatide.

Score Breakdown

Value25%
9
Effectiveness25%
7.5
User Experience15%
7
Trust & Safety15%
7.3
Accessibility10%
7.5
Support10%
7

Pros

  • ✓Aggressively low monthly pricing
  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access

Cons

  • ✗Limited public information on program details
Starting from $75/moRead full review →
Visit Ivim Health →
4

Embody

Verified partner

Best for: low flat-rate compounded GLP-1 pricing at every dose

7.8

Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation. Aggressive flat-rate pricing with all 50 states and a 24/7 clinician messaging model led by a board-certified internal medicine CMO.

Score Breakdown

Value25%
8.5
Effectiveness25%
8
User Experience15%
7
Trust & Safety15%
6.8
Accessibility10%
8.5
Support10%
8

Pros

  • ✓Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • ✓Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • ✓Available in all 50 states with no insurance friction
  • ✓24/7 unlimited clinician messaging and dose-adjustment support included
  • ✓Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Cons

  • ✗The $79 rate is an auto-applied promo 'locked forever'; the terms list $199/mo and reviewers allege the lock isn't honored
  • ✗Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • ✗Pharmacy partners not publicly named — compounding source transparency is limited
  • ✗Compounded oral tirzepatide has no FDA-approved counterpart, and oral GLP-1 bioavailability is still clinically debated
Starting from $79/moRead full review →
Visit Embody →
5

GobyMeds

Verified partner

Best for: budget-conscious shoppers

8.1

Affordable telehealth provider offering compounded semaglutide only.

Score Breakdown

Value25%
9.5
Effectiveness25%
8
User Experience15%
7.5
Trust & Safety15%
7.3
Accessibility10%
8
Support10%
7.4

Pros

  • ✓Aggressively low monthly pricing
  • ✓Compounded GLP-1 access

Cons

  • ✗Limited public information on program details
Starting from $93/moRead full review →
Visit GobyMeds →

How to find the cheapest legitimate semaglutide

The lowest price only helps if the provider is trustworthy. Here's how to tell a genuinely cheap-and-legitimate semaglutide provider from a cut-rate risk.

What to look for

  • Cheapest legit ≠ cheapest overall. The lowest number on a list isn't always the safest. Cross-check the price against the provider's trust score and pharmacy disclosure before you buy.
  • Watch the plan length. The lowest per-month prices usually require a 3- or 12-month prepay. If you're not sure semaglutide is right for you, a slightly higher month-to-month price can be the cheaper mistake to make.
  • Total cost, dose-adjusted. Confirm the price holds as your dose increases, and add any membership fee, to get the true cheapest option.

Red flags to avoid

  • No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
  • Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
  • Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
  • Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.

Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Frequently Asked Questions

The lowest cash prices come from compounded semaglutide on longer plans — often under $150/month — versus $1,000+ for brand-name Wegovy or Ozempic without insurance. The list above is sorted by the lowest real monthly price; watch for membership fees and dose-based increases that raise the true total.
No. Compounded semaglutide is priced for cash-pay patients and doesn't require insurance. For brand-name Wegovy or Ozempic, the manufacturer savings card can lower the cost for eligible insured patients, but the cheapest overall route for most people is a compounded provider from the ranked list above.
A lower price doesn't mean a weaker drug — compounded semaglutide uses the same active ingredient as Wegovy. Safety depends on the pharmacy: verify a named 503A/503B pharmacy and LegitScript certification. The cheapest listing and the cheapest legitimate option aren't always the same, which is why we show each provider's trust score.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.
Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Related Rankings